Updated 46 days ago
- Age: 28 years
- ID: 26896681/5
CLICK HERE TO SEE DETAILS OF COMPANY CHANGES
At ResMed, we are constantly thinking beyond the horizon and challenging ourselves to remain visionaries of the industry we created. We've always done things our own way. With integrity. With passion. And with the aspiration to improve lives with our expertise...
In 1981, Professor Colin Sullivan of the University of Sydney created the first continuous positive airway pressure (CPAP) device. Built from a reverse vacuum cleaner pump, the device was the first noninvasive treatment for obstructive sleep apnea. While many saw its potential, only Dr. Peter Farrell recognized a commercial opportunity. In 1989, he founded ResMed to advance the treatment of sleep apnea, and in 1995, we began trading on NASDAQ. In 1999, we transferred our principal public listing to the NYSE. In late 1999, we established a secondary listing of our common stock on the Australian Stock Exchange...
At ResMed, every team member at every level of the organization can do extraordinary work and deliver innovation. I..